Comparative efficacy and acceptability of antimanic drugs in acute mania: a multiple-treatments meta-analysis

  title={Comparative efficacy and acceptability of antimanic drugs in acute mania: a multiple-treatments meta-analysis},
  author={Andrea Cipriani and Corrado Barbui and Georgia Salanti and Jennifer M. Rendell and Rachel Brown and Sarah Stockton and Marianna Purgato and Loukia Maria Spineli and Guy M. Goodwin and John R. Geddes},
  journal={The Lancet},

Figures from this paper

First-Generation Versus Second-Generation Antipsychotics in Adults : Comparative Effectiveness
Overall, antipsychotic drugs were significantly more effective than mood stabilisers and should be considered as among the best of the available options for the treatment of manic episodes.
The Efficacy and Tolerability of Paliperidone in Mania of Bipolar Disorder: A Preliminary Meta-Analysis
The preliminary results suggest that paliperidone does not offer significant benefits for the treatment of mania symptoms in BD compared with a placebo, and treatment with palipersidone was associated with a higher incidence of adverse effects.
The Comparison of the Effectiveness of Thiothixene and Risperidone as a Combination with Lithium for the Treatm ent of Patients with Bipolar Disorder
Thiothixene is as effective as risperidone in the improvement of manic and psychotic symptoms, so it can be used as an appropriate combination with lithium for the treatment of bipolar patients in psychotic manic episode.
Efficacy and tolerability of asenapine for acute mania in bipolar I disorder: meta-analyses of randomized-controlled trials
The aim of this study was to quantitatively review, using a meta-analytic approach, randomized-controlled trials analyzing the efficacy and safety profiles of asenapine in the treatment of bipolar
Acceptability of Acute and Maintenance Pharmacotherapy of Bipolar Disorder: A Systematic Review of Randomized, Double-Blind, Placebo-Controlled Clinical Trials.
All medications studied in bipolar disorder were relatively well tolerated during different phases of treatment; however, the risk for short- and long-term WG and somnolence varied widely among included psychotropics.


Efficacy of Antimanic Treatments: Meta-analysis of Randomized, Controlled Trials
We conducted meta-analyses of findings from randomized, placebo-controlled, short-term trials for acute mania in manic or mixed states of DSM (III–IV) bipolar I disorder in 56 drug–placebo
Second-generation antipsychotic agents in the treatment of acute mania: a systematic review and meta-analysis of randomized controlled trials.
Combining SGAs and MSs is the most efficacious treatment of acute mania, and adding antipsychotic agents to MS treatment was significantly more effective than treatment with MSs alone.
Level of response and safety of pharmacological monotherapy in the treatment of acute bipolar I disorder phases: a systematic review and meta-analysis.
It is concluded that most MDRs were efficacious and safe in the treatment of manic episodes, but very few M DRs have demonstrated being efficacious for bipolar depressive episodes.
Limitations in randomised controlled trials evaluating drug effects in mania
  • R. Licht
  • Psychology
    European archives of psychiatry and clinical neuroscience
  • 2001
This paper addresses some issues related to RCTs on drug effects in mania, including a discussion of various response criteria based on mania rating scale scores and the issues arising from the unusual high drop-out rates.
A systematic review and economic model of the clinical effectiveness and cost-effectiveness of interventions for preventing relapse in people with bipolar disorder.
Lithium, valproate, lamotrigine and olanzapine are effective as maintenance therapy for the prevention of relapse in bipolar disorder and lithium is the most cost-effective therapy.
Eff ectiveness of antipsychotic drugs in fi rst-episode schizophrenia and schizophreniform disorder : an open randomised clinical trial
An open randomised controlled trial of haloperidol versus second-generation antipsychotic drugs in 50 sites, in 14 countries, and met diagnostic criteria for schizophrenia, schizophreniform disorder, or schizoaff ective disorder.
Antipsychotic and mood stabilizer efficacy and tolerability in pediatric and adult patients with bipolar I mania: a comparative analysis of acute, randomized, placebo-controlled trials.
In treating mania, potentially greater short-term efficacy compared to placebo with SGAs versus MS needs to be balanced against increased adverse events, especially in youth.